Hepatitis Monthly
Official Journal of Research Center for Gastroenterology and Liver Diseases
Scopus by Title (Ref)
1. Interleukin 10 Cytokine Polymorphism (rs1800896) Association with the Hepatitis C in Patients from Iraq
- Al-Shihani A.M. , et al.
2. HCV immunodominant peptide mapping reveals unique HLA-A*02-restricted signatures: insights for CD8+ T-cell-based vaccines and immunotherapies
- Cardoso Corrêa-Dias L. , et al.
3. Interleukin-10 and interferon-gamma serum levels correlation with some liver function parameters in hepatitis C chronically infected patients
- Abbas A.H. , et al.
4. Role of Inflammatory/Immune Response and Cytokine Polymorphisms in the Severity of Chronic Hepatitis C (CHC) before and after Direct Acting Antiviral (DAAs) Treatment
- Ferreira J. , et al.
5. Negative Correlation of Interleukin-38 Serum Level with Alkaline Phosphatase and Persistent Hepatitis C Infection
- Rokhtabnak N. , et al.
6. T helper type (Th1/Th2) responses to SARS-CoV-2 and influenza A (H1N1) virus: From cytokines produced to immune responses
- Aleebrahim-Dehkordi E. , et al.
7. Low Mannose Binding Lectin, but Not L-Ficolin, Is Associated With Spontaneous Clearance of Hepatitis C Virus After Infection
- Zhang J. , et al.
8. Optimized hepatitis C virus (HCV) e2 glycoproteins and their immunogenicity in combination with MVA-HCV
- Marín M.Q. , et al.
9. Polymorphisms in the TGFB1 and FOXP3 genes are associated with the presence of antinuclear antibodies in chronic hepatitis C
- de Castro G.L.C. , et al.
10. Dynamic changes in innate immune responses during direct-acting antiviral therapy for HCV infection
- Holmes J.A. , et al.
11. Association of IL-1β, IL-1RN, and ESR1 genes polymorphism with risk of infection and response to sofosbuvir plus daclatasvir combination therapy in hepatitis C virus genotype-4 patients
- Khairy R.M. , et al.
12. Serum levels of interleukin-4, interleukin-10 and interferon-γ in patients with chronic hepatitis B infection
- Khorami S.H.H. , et al.
13. First report of HTLV-1 truncated p12 protein in Brazil
- Rosadas C. , et al.
14. Cytokine profile in chronic hepatitis C: An observation
- Baskic D. , et al.
15. Association of immune response parameters with virological response in hepatitis C virus patients treated with pegylated consensus interferon
- Ding Y. , et al.
16. Liver and blood cytokine microenvironment in HCV patients is associated to liver fibrosis score: A proinflammatory cytokine ensemble orchestrated by TNF and tuned by IL-10 Microbe-host interactions and microbial pathogenicity
- De Souza-Cruz S. , et al.
17. Genetic association between Interleukin-12 Receptor B1 Polymorphism (rs3746190 A/G) and susceptibility to chronic hepatitis B virus infection
- Salehi M. , et al.
18. Association of colonic regulatory T cells with hepatitis C virus pathogenesis and liver pathology
- Hetta H.F. , et al.
19. Delayed liver fibrosis in HTLV-2-infected patients co-infected with HIV-1 and hepatitis C virus with suppressive antiretroviral therapy
- Abad-Fernández M. , et al.
20. Human T-lymphotropic virus type 2 subtype b in a patient with chronic neurological disorder
- Rosadas C. , et al.
21. The role of interferon gamma gene polymorphism (+874A/T, +2109A/G, and -183G/T) in response to treatment among hepatitis C infected patients in Fars Province, Southern Iran
- Sarvari J. , et al.
22. Evaluation of serum levels of IL-6, TNF-α, IL-10, IL-2 and IL-4 in patients with chronic hepatitis
- Mourtzikou A. , et al.
23. IL-10: Achieving balance during persistent viral infection
- Ng C. , et al.
24. Controversial concepts regarding T helper 1 and T helper 2 cytokines in hepatitis C virus infected patients
- Noroozi Karimabad M. , et al.